Puma Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lies and cover ups. And index schmindex. Word on the street is inactively managed funds are the place to be in 2015. They have not been for the recent years. We are going to ask a very simple but very important question today, why the difference in 2015 . The nba commissioner adam silver if nothing else his own man writing an oped in todays New York Times in favor of legalizing prosports gambling saying it should be brought out of the underground and into the sun light. Silver cited a new jersey bill as an example for the appetite for Online Gambling and said congress should adopt a federal fr...

Up lets get you up to speed on the markets. U. S. Equity futures are suggesting a positive open and implied open of 70 points for the dow and s p nearly 9 and for the nasdaq a little more than 24 points. Right where we were yesterday before the retail sales report. Heres the other big stories were watching today. Two economic reports due at 8 30 eastern. Well hear from kohls before the bell and this afternoon watch for nordstrom among others and in Corporate News General Electric is going to sell its commercial finance business. This is part of the plan to spin off most of ge capital. The busi...

Quadrupling after an experimental drug blocks the return of Breast Cancer in women. Blue chip records, the s p 500 fyl out a small gai 300 , thats quadruple. Another big gainer saw shares climb 11 on surging sales of its ms treatment. Meg terrell has more on this big day in biotech, what is behind the numbers at puma and bio again and what investors can look forward to. Reporter stocks are known for versatility, big risk, big reward. Puma soared on the drug for Breast Cancer. In a trial of more than 2,000 patients the medicine helps people live for 33 longer without disease professing. The dru...

Experimental drug blocks the return of Breast Cancer in women. Blue chip records, the s p 500 fyl out a small gai 300 , thats quadruple. Another big gainer saw shares climb 11 on surging sales of its ms treatment. Meg terrell has more on this big day in biotech, what is behind the numbers at puma and bio again and what investors can look forward to. Reporter stocks are known for versatility, big risk, big reward. Puma soared on the drug for Breast Cancer. In a trial of more than 2,000 patients the medicine helps people live for 33 longer without disease professing. The drug was tested for a sp...

Experimental drug blocks the return of Breast Cancer in women. Blue chip records, the s p 500 fyl out a small gai 300 , thats quadruple. Another big gainer saw shares climb 11 on surging sales of its ms treatment. Meg terrell has more on this big day in biotech, what is behind the numbers at puma and bio again and what investors can look forward to. Reporter stocks are known for versatility, big risk, big reward. Puma soared on the drug for Breast Cancer. In a trial of more than 2,000 patients the medicine helps people live for 33 longer without disease professing. The drug was tested for a sp...